Bremer Bank National Association Bristol Myers Squibb CO Transaction History

Bremer Bank National Association

$526 Million
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$40.25 - $52.99 $73,174 - $96,335	-1,818 Reduced 27.33%	4,834 $200,000
Q1 2024 Apr 17, 2024	SELL	$47.98 - $54.4 $64,005 - $72,569	-1,334 Reduced 16.7%	6,652 $360,000
Q4 2023 Jan 11, 2024	SELL	$48.48 - $57.85 $31,027 - $37,024	-640 Reduced 7.42%	7,986 $409,000
Q3 2023 Oct 20, 2023	SELL	$57.89 - $64.73 $57,716 - $64,535	-997 Reduced 10.36%	8,626 $500,000
Q2 2023 Jul 17, 2023	SELL	$63.71 - $70.74 $116,525 - $129,383	-1,829 Reduced 15.97%	9,623 $615,000
Q1 2023 Apr 13, 2023	SELL	$65.71 - $74.53 $100,799 - $114,329	-1,534 Reduced 11.81%	11,452 $793,000
Q4 2022 Jan 12, 2023	SELL	$68.48 - $81.09 $157,709 - $186,750	-2,303 Reduced 15.06%	12,986 $934,000
Q3 2022 Oct 12, 2022	SELL	$0.13 - $76.84 $451 - $266,942	-3,474 Reduced 18.52%	15,289 $1.09 Million
Q2 2022 Jul 08, 2022	SELL	$72.62 - $79.98 $118,152 - $130,127	-1,627 Reduced 7.98%	18,763 $1.45 Million
Q1 2022 Apr 07, 2022	SELL	$61.48 - $73.72 $1.07 Million - $1.28 Million	-17,352 Reduced 45.98%	20,390 $1.49 Million
Q4 2021 Jan 10, 2022	SELL	$53.63 - $62.52 $501,655 - $584,812	-9,354 Reduced 19.86%	37,742 $2.35 Million
Q3 2021 Oct 05, 2021	SELL	$59.17 - $69.31 $116,742 - $136,748	-1,973 Reduced 4.02%	47,096 $2.79 Million
Q2 2021 Jul 13, 2021	SELL	$61.91 - $67.42 $124,810 - $135,918	-2,016 Reduced 3.95%	49,069 $3.28 Million
Q1 2021 Apr 07, 2021	SELL	$59.34 - $66.74 $73,878 - $83,091	-1,245 Reduced 2.38%	51,085 $3.23 Million
Q4 2020 Jan 12, 2021	SELL	$57.74 - $65.43 $23,731 - $26,891	-411 Reduced 0.78%	52,330 $3.25 Million
Q3 2020 Oct 22, 2020	BUY	$57.43 - $63.64 $56,223 - $62,303	979 Added 1.89%	52,741 $3.18 Million
Q2 2020 Jul 28, 2020	SELL	$54.82 - $64.09 $150,261 - $175,670	-2,741 Reduced 5.03%	51,762 $3.04 Million
Q1 2020 Apr 17, 2020	SELL	$46.4 - $67.43 $281,044 - $408,423	-6,057 Reduced 10.0%	54,503 $3.04 Million
Q4 2019 Jan 27, 2020	BUY	$49.21 - $64.19 $876,380 - $1.14 Million	17,809 Added 41.66%	60,560 $3.89 Million
Q3 2019 Oct 03, 2019	SELL	$42.77 - $50.71 $898 - $1,064	-21 Reduced 0.05%	42,751 $2.17 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $61,798 - $68,335	1,385 Added 3.35%	42,772 $1.94 Million
Q1 2019 May 09, 2019	BUY	$45.12 - $53.8 $1.87 Million - $2.23 Million	41,387 New	41,387 $1.92 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.24 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.41 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.54 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.55 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bremer Bank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Bremer Bank National Association with notifications on news.

Account